Rise in incidences of facial fractures is expected to fuel growth of the craniomaxillofacial implants market in the near future

Google+ Pinterest LinkedIn Tumblr +

Craniomaxillofacial is a special branch of orthopedic surgery, which focuses on all the aspects of facial and skull disorders. The craniomaxillofacial implant surgery is carried out to treat a severe injury of facial and cranial bones, where the implants are temporarily or permanently placed in the body. Traumas, accidents, and genetic defects lead to craniomaxillofacial deformities. Craniomaxillofacial implants surgery is also carried out to correct abnormalities and deformities caused by diseases, such as Crouzon’s disease and Apert’s Syndrome. Initially, the emphasis was just on keeping absolute stability of the bones, without much attention on free movements. However, owing to advancements in technology and implant materials such as biocompatible titanium implants, resorbable plates, screws, and bone grafts, have increased the scope for maintaining stability as well as functionality of the joints, allowing for ease of treatments related to craniomaxillofacial deformities. Furthermore, lack of other alternatives for facial surgeries is expected to favor the craniomaxillofacial implants market. Birth defects such as cleft palate and anotia are also treated through craniomaxillofacial surgeries. According to the Centers for Disease Control and Prevention in the U.S., around 2,650 babies are recorded to be born with a cleft palate, every year. Improvement in implant materials and minimal invasiveness of this type of surgery is increasing its demand among the populace.

To understand Research Methodology, please click: https://www.coherentmarketinsights.com/insight/request-sample/773 

The global craniomaxillofacial implant market was valued at US$ 1,907.9 million in 2016 and is expected to witness a robust CAGR of 6.2% over the forecast period (2017-2025).

Few growth restraining factors are the high costs associated with craniomaxillofacial surgeries and low availability of skilled surgeons.

North America accounts for the largest share in the global craniomaxillofacial implants market, followed by Europe. This is mainly attributed to the presence of skilled surgeons in North America. Moreover, according to Center for Disease Control and Prevention in the U.S., around 2 million high school athletes are reported with injuries, with head injuries accounting for 14%each year. The craniomaxillofacial implants market is expected to exhibit a high growth rate in the Asia-Pacific region over the forecast period, supported by increasing prevalence of road accidents. Increasing expenditures on healthcare by the population and increasing rate of sports-related injuries supports growth of the craniomaxillofacial implants market.

Furthermore, increasing geriatric population, being more prone to higher risk injuries due to their weak skeletal system, are expected to favor growth of the market According to National Institute on Aging, , 524 million people were recorded to be 65 years of age and above , accounting for 8% of the world’s population in 2010, which is expected to triple in number to 1.5 billion, representing 16% of the world’s population by 2050.

Improved craniomaxillofacial implant materials and advent of new technologies associated with surgeries are expected to drive the craniomaxillofacial implants market

Patient specific implants, 3D implants, growing demand for bioresorbable materials, and growing adoption of robot assisted surgeries have simplified the complexity of craniomaxillofacial surgeries. Whereas, advanced techniques, including computer-assisted craniofacial reconstruction, distraction osteogenesis, and endoscopic procedures, combined with refinements in surgical equipment such as resorbable plating and distractors, have improved surgical outcomes, while minimizing morbidity. The development of bone graft substitutes with the help of gene therapy and nanotechnology is also expected to drive the craniomaxillofacial implants market.

Ask for customization: https://www.coherentmarketinsights.com/insight/request-customization/773

Some major players operating in the craniomaxillofacial implants market include Stryker Corporation, Johnson & Johnson, Zimmer Biomet Holdings, Inc., Medtronic plc, Integra LifeSciences Holdings Corporation, OsteoMed L.P., Medartis AG, KLS Martin, Calavera Surgical Design, and Matrix Surgicssal USA.


About Author

Is an excellent researcher with expertise in the healthcare domain. His detailed research on topics related to recent breakthroughs in the genetic engineering, pharmacy, and healthcare fields coupled with his ability to concise his in-depth study in the best way possible, is of great advantage to this new portal. Contact Author

Comments are closed.